In vivo fate and intracellular trafficking of vaccine delivery systems.

Authors:
Lee J; Kim D; Byun J; Wu Y; Park J and 1 more

Journal:
Adv Drug Deliv Rev

Publication Year: 2022

DOI:
10.1016/j.addr.2022.114325

PMCID:
PMC9085465

PMID:
35550392

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Adv Drug Deliv Rev

Abbreviation: Adv Drug Deliv Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Drug Therapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y. (2023) - Transparency Score: 3/6
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery.
Han G; Noh D; Lee H and 4 more (2023) - Transparency Score: 3/6
Imaging drug delivery to the lungs: Methods and applications in oncology.
Man F; Tang J; Swedrowska M and 2 more (2022) - Transparency Score: 3/6
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.
Aldarondo D; Wayne E. (2022) - Transparency Score: 3/6
Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic thera…
Hunt NJ; Wahl D; Westwood LJ and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This research was funded by grants from the National 10.13039/100005930Research Foundation (NRF) of Korea, Ministry of Science and ICT, Republic of Korea (NRF-2021R1A2B5B03002123; NRF-2018R1A5A2024425; NRF-2021K2A9A2A06037695; NRF-2022M3E5F1017919); Basic Science Research Program through the NRF funded by Ministry of Education (NRF-2020R1A6A3A01099750); the Korean Health Technology R&D Project (No. HI19C0664), Ministry of Health & Welfare, Republic of Korea."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025